MUC2 and MUC6 apomucins expression in human gastric neoplasm: an immunohistochemical analysis

[1]  W. Khan,et al.  Mucin Gene Deficiency in Mice Impairs Host Resistance to an Enteric Parasitic Infection , 2010, Gastroenterology.

[2]  S. Batra,et al.  Mucin-interacting proteins: from function to therapeutics. , 2010, Trends in biochemical sciences.

[3]  S. Matsumoto,et al.  Clinicopathological and prognostic significance of mucin phenotype in gastric cancer , 2008, Journal of surgical oncology.

[4]  Sang Hyun Kim,et al.  Increased expression of mucin 5AC mRNA and decreased expression of epidermal growth-factor receptor mRNA in gallstone patients. , 2008, The Tohoku journal of experimental medicine.

[5]  Hua-Chuan Zheng,et al.  Mixed-type gastric carcinomas exhibit more aggressive features and indicate the histogenesis of carcinomas , 2008, Virchows Archiv.

[6]  J. Meijerink,et al.  Muc2-deficient mice spontaneously develop colitis, indicating that MUC2 is critical for colonic protection. , 2006, Gastroenterology.

[7]  M. Copin,et al.  Relationships between mucinous gastric carcinoma, MUC2 expression and survival. , 2006, World journal of gastroenterology.

[8]  K. Herzig,et al.  Defensin expression in chronic pouchitis in patients with ulcerative colitis or familial adenomatous polyposis coli. , 2006, World journal of gastroenterology.

[9]  H. Devaraj,et al.  Expression profile of mucins (MUC2, MUC5AC and MUC6) in Helicobacter pylori infected pre-neoplastic and neoplastic human gastric epithelium , 2006, Molecular Cancer.

[10]  Toshikazu Yamaguchi,et al.  Mucin phenotypic expression and p53 gene abnormality of gastric super-minute well-differentiated adenocarcinoma: Re-evaluation with relationship between histogenesis of well-differentiated adenocarcinoma and intestinal metaplasia in distal stomach , 2005, Journal of carcinogenesis.

[11]  A. Hölscher,et al.  Co-expression of CDX2 and MUC2 in gastric carcinomas: correlations with clinico-pathological parameters and prognosis. , 2005, World journal of gastroenterology.

[12]  A. Soran,et al.  Prognostic Significance of Mucin Expression in Gastric Carcinoma , 2004, Digestive Diseases and Sciences.

[13]  P. Blok,et al.  Prevalence of subtypes of intestinal metaplasia in gastric antral mucosa , 1991, Digestive Diseases and Sciences.

[14]  P. Chu,et al.  Differential expression of MUC1, MUC2, and MUC5AC in carcinomas of various sites: an immunohistochemical study. , 2004, American journal of clinical pathology.

[15]  S. Kitano,et al.  Re‐evaluation of mucin phenotypes of gastric minute well‐differentiated‐type adenocarcinomas using a series of HGM, MUC5AC, MUC6, M‐GGMC, MUC2 and CD10 stains , 2004, Pathology international.

[16]  P. Roepstorff,et al.  Development and characterization of an antibody directed to an α-N-acetyl-D-galactosamine glycosylated MUC2 peptide , 2004, Glycoconjugate Journal.

[17]  D. Fang,et al.  Alterations of MUC1 and MUC3 expression in gastric carcinoma: relevance to patient clinicopathological features , 2003, Journal of clinical pathology.

[18]  G. Klöppel,et al.  How do gastric carcinoma classification systems relate to mucin expression patterns? An immunohistochemical analysis in a series of advanced gastric carcinomas , 2002, Virchows Archiv.

[19]  A. Dursun,et al.  Expression of MUC1 and MUC2 mucins in gastric carcinomas: their relationship with clinicopathologic parameters and prognosis. , 2002, Pathology, research and practice.

[20]  C. Reis,et al.  Mucins MUC1, MUC2, MUC5AC and MUC6 expression in the evaluation of differentiation and clinico-biological behaviour of gastric carcinoma , 2002, Virchows Archiv.

[21]  V. Yajnik,et al.  Pathology and genetics of tumors of the digestive system , 2001 .

[22]  C. Probert,et al.  Mucins in the gastrointestinal tract in health and disease. , 2001, Frontiers in bioscience : a journal and virtual library.

[23]  H. Lee,et al.  MUC1, MUC2, MUC5AC, and MUC6 expressions in gastric carcinomas , 2001, Cancer.

[24]  M. Kusano,et al.  Gastric and Intestinal Phenotypic Marker Expression in Gastric Carcinomas and Its Prognostic Significance: Immunohistochemical Analysis of 136 Lesions , 2001, Oncology.

[25]  L. Sobin,et al.  World Health Organization classification of tumors , 2000, Cancer.

[26]  M. Akiyama,et al.  Genetic instability in intestinal metaplasia is a frequent event leading to well-differentiated early adenocarcinoma of the stomach. , 2000, European journal of cancer.

[27]  M. Sobrinho-Simões,et al.  Immunohistochemical Study of the Expression of MUC6 Mucin and Co-expression of Other Secreted Mucins (MUC5AC and MUC2) in Human Gastric Carcinomas , 2000, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[28]  M. Sobrinho-Simões,et al.  Gastric carcinoma exhibits distinct types of cell differentiation: an immunohistochemical study of trefoil peptides (TFF1 and TFF2) and mucins (MUC1, MUC2, MUC5AC, and MUC6) , 2000, The Journal of pathology.

[29]  Y. Kim,et al.  Forskolin and phorbol ester have opposite effects on the expression of mucin-associated sialyl-Lewis(a) in pancreatic cancer cells. , 2000, European journal of cancer.

[30]  J. Arends,et al.  Classification of gastric carcinoma using the Goseki system provides prognostic information additional to TNM staging , 1999, Cancer.

[31]  M. Sobrinho-Simões,et al.  Patterns of expression of trefoil peptides and mucins in gastric polyps with and without malignant transformation , 1999, The Journal of pathology.

[32]  M. Sobrinho-Simões,et al.  Intestinal metaplasia of human stomach displays distinct patterns of mucin (MUC1, MUC2, MUC5AC, and MUC6) expression. , 1999, Cancer research.

[33]  P. Desreumaux,et al.  Abnormalities in mucin gene expression in Crohn's disease , 1999 .

[34]  T. Irimura,et al.  Expression of MUC1 and MUC2 mucins in gastric carcinomas: its relationship with the prognosis of the patients. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

[35]  S. Baldus,et al.  Correlation of the immunohistochemical reactivity of mucin peptide cores MUC1 and MUC2 with the histopathological subtype and prognosis of gastric carcinomas , 1998, International journal of cancer.

[36]  S. Yonezawa,et al.  Expression of mucin antigens in human cancers and its relationship with malignancy potential , 1997, Pathology international.

[37]  Y. Kim,et al.  Mucin antigen expression in gastric carcinomas of young and old adults. , 1997, Human pathology.

[38]  P. Roepstorff,et al.  Immunohistochemical study of MUC5AC expression in human gastric carcinomas using a novel monoclonal antibody , 1997, International journal of cancer.

[39]  M F Dixon,et al.  Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. , 1996, The American journal of surgical pathology.

[40]  M. Price,et al.  Expression of a peptide epitope of the colonic mucin MUC2 in precursor lesions to gastric carcinoma , 1996, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[41]  M Garrido,et al.  MUC6 apomucin shows a distinct normal tissue distribution that correlates with Lewis antigen expression in the human stomach. , 1995, Gastroenterology.

[42]  Y. Kim,et al.  Mucin gene expression in normal, preneoplastic, and neoplastic human gastric epithelium. , 1995, Cancer research.

[43]  S. Gendler,et al.  Epithelial mucin genes. , 1995, Annual review of physiology.

[44]  T. Lesuffleur,et al.  Mucins in normal and neoplastic human gastrointestinal tissues. , 1994, Critical reviews in oncology/hematology.

[45]  F. Real,et al.  Differential apomucin expression in normal and neoplastic human gastrointestinal tissues. , 1994, Gastroenterology.

[46]  T. Rokkas,et al.  Detection of an increased incidence of early gastric cancer in patients with intestinal metaplasia type III who are closely followed up. , 1991, Gut.

[47]  J. Crabtree,et al.  Glycoprotein synthesis and secretion by cultured small intestinal mucosa in coeliac disease. , 1989, Gut.

[48]  P. Correa,et al.  A human model of gastric carcinogenesis. , 1988, Cancer research.

[49]  C. Boland,et al.  Alterations in human colonic mucin occurring with cellular differentiation and malignant transformation. , 1982, Proceedings of the National Academy of Sciences of the United States of America.